Indian Pharma CEO Warns U.S. Tariffs Could Raise Generic Drug Prices
The CEO of Dr. Reddy's Laboratories warned that proposed tariffs by President Trump could significantly increase the cost of generic drugs in the U.S., as Indian companies produce nearly half of these medicines and operate on thin margins.
Tickers: $RDY
Topics: generic drugs pharmaceuticals trade policy